• 1
    Breslow A. Prognosis in cutaneous melanoma: tumor thickness as a guide to treatment. Pathol Annu 1980; 15: 122.
  • 2
    Bafounta ML, Beauchet A, Aegerter P, Saiag P. Is dermoscopy (epiluminescence microscopy) useful for the diagnosis of melanoma? Results of a meta-analysis using techniques adapted to the evaluation of diagnostic tests. Arch Dermatol 2001; 137: 134350.
  • 3
    Vestergaard ME, Macaskill P, Holt PE, Menzies SW. Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting. Br J Dermatol 2008; 159: 66976.
  • 4
    Pehamberger H, Steiner A, Wolff K. In vivo epiluminescence microscopy of pigmented skin lesions. I. Pattern analysis of pigmented skin lesions. J Am Acad Dermatol 1987; 17: 57183.
  • 5
    Argenziano G, Fabbrocini G, Carli P et al. Epiluminescence microscopy for the diagnosis of doubtful melanocytic skin lesions. Comparison of the ABCD rule of dermatoscopy and a new 7-point checklist based on pattern analysis. Arch Dermatol 1998; 134:156370.
  • 6
    Nachbar F, Stolz W, Merkle T et al. The ABCD rule of dermatoscopy. High prospective value in the diagnosis of doubtful melanocytic skin lesions. J Am Acad Dermatol 1994; 30: 5519.
  • 7
    Carli P, Massi D, deGiorgi V, Giannotti B. Clinically and dermoscopically featureless melanoma: when prevention fails. J Am Acad Dermatol 2002; 46: 9579.
  • 8
    Haenssle HA, Vente C, Bertsch HP et al. Results of a surveillance programme for patients at high risk of malignant melanoma using digital and conventional dermoscopy. Eur J Cancer Prev 2004; 13: 1338.
  • 9
    Haenssle HA, Krueger U, Vente C et al. Results from an observational trial: digital epiluminescence microscopy follow-up of atypical nevi increases the sensitivity and the chance of success of conventional dermoscopy in detecting melanoma. J Invest Dermatol 2006; 126: 9805.
  • 10
    Kittler H, Guitera P, Riedl E et al. Identification of clinically featureless incipient melanoma using sequential dermoscopy imaging. Arch Dermatol 2006; 142: 11139.
  • 11
    Altamura D, Avramidis M, Menzies SW. Assessment of the optimal interval for and sensitivity of short-term sequential digital dermoscopy monitoring for the diagnosis of melanoma. Arch Dermatol 2008; 144: 5026.
  • 12
    Menzies SW, Gutenev A, Avramidis M et al. Short-term digital surface microscopic monitoring of atypical or changing melanocytic lesions. Arch Dermatol 2001; 137: 15839.
  • 13
    Bauer J, Blum A, Strohhacker U, Garbe C. Surveillance of patients at high risk for cutaneous malignant melanoma using digital dermoscopy. Br J Dermatol 2005; 152: 8792.
  • 14
    Haenssle HA, Korpas B, Hansen-Hagge C et al. Selection of patients for long-term surveillance with digital dermoscopy by assessment of melanoma risk factors. Arch Dermatol 2010; 146: 25764.
  • 15
    Robinson JK, Nickoloff BJ. Digital epiluminescence microscopy monitoring of high-risk patients. Arch Dermatol 2004; 140: 4956.
  • 16
    Salerni G, Carrera C, Lovatto L et al. Benefits of total body photography and digital dermatoscopy (“two-step method of digital follow-up”) in the early diagnosis of melanoma in patients at high risk for melanoma. J Am Acad Dermatol 2012; 67: e17e27.
  • 17
    Gandini S, Sera F, Cattaruzza MS et al. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 2005; 41: 204059.
  • 18
    Gandini S, Sera F, Cattaruzza MS et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005; 41: 4560.
  • 19
    Gandini S, Sera F, Cattaruzza MS et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 2005; 41: 2844.
  • 20
    Stam-Posthuma JJ, vanDuinen C, Scheffer E et al. Multiple primary melanomas. J Am Acad Dermatol 2001; 44: 227.
  • 21
    Braun RP, Lemonnier E, Guillod J et al. Two types of pattern modification detected on the follow-up of benign melanocytic skin lesions by digitized epiluminescence microscopy. Melanoma Res 1998; 8: 4317.
  • 22
    Schiffner R, Schiffner-Rohe J, Landthaler M, Stolz W. Long-term dermoscopic follow-up of melanocytic naevi: clinical outcome and patient compliance. Br J Dermatol 2003; 149: 7986.
  • 23
    Kittler H, Pehamberger H, Wolff K, Binder M. Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi. J Am Acad Dermatol 2000; 43: 46776.
  • 24
    Buhl T, Hansen-Hagge C, Korpas B et al. Integrating static and dynamic features of melanoma: the DynaMel algorithm. J Am Acad Dermatol 2012; 66: 2736.
  • 25
    Argenziano G, Mordente I, Ferrara G et al. Dermoscopic monitoring of melanocytic skin lesions: clinical outcome and patient compliance vary according to follow-up protocols. Br J Dermatol 2008; 159: 3316.
  • 26
    Salerni G, Teran T, Puig S et al. Meta-analysis of digital dermoscopy follow-up of melanocytic skin lesions: a study on behalf of the International Dermoscopy Society. J Eur Acad Dermatol Venereol 2012 Nov 26. [Epub ahead of print].